APDN - Applied Dna Sciences Inc
IEX Last Trade
1.895
-0.315 -16.623%
Share volume: 3,981,720
Last Updated: Fri 30 Aug 2024 09:59:48 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$2.21
-0.32
-14.25%
Fundamental analysis
26%
Profitability
27%
Dept financing
16%
Liquidity
75%
Performance
15%
Performance
5 Days
-24.80%
1 Month
396.10%
3 Months
215.70%
6 Months
-83.98%
1 Year
-92.42%
2 Year
-96.40%
Key data
Stock price
$1.90
DAY RANGE
N/A - N/A
52 WEEK RANGE
$0.31 - $28.40
52 WEEK CHANGE
-$0.93
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
12/05/2024
Company detail
CEO: James Hayward
Region: US
Website: http://www.adnas.com/
Employees: 72
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: http://www.adnas.com/
Employees: 72
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
we keep life real and safe by providing botanical-dna based security and authentication solutions and services that protect assets, products, brands, supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion.
Recent news